Challenging the Status Quo: Dr. Martin Makary Faces Senate Scrutiny on FDA Vaccine Advisory Committee Changes March 6, 2025
Jazz Pharmaceuticals Strikes $935 Million Deal to Acquire Chimerix and Boost Oncology Pipeline with Promising Brain Cancer Treatment March 6, 2025
Jazz Pharmaceuticals Acquires Chimerix for $935 Million to Bolster Oncology Portfolio with Promising Brain Cancer Treatment March 6, 2025
Jazz Pharmaceuticals Acquires Chimerix for $935 Million, Paving the Way for Innovative Brain Cancer Treatment March 6, 2025
Jazz Pharmaceuticals to Acquire Chimerix for $935 Million, Paving the Way for Promising Brain Cancer Treatment March 5, 2025
Jazz Pharmaceuticals Aims High: $935 Million Acquisition of Chimerix to Enhance Oncology Portfolio with Promising Brain Cancer Treatment March 5, 2025
Sofinnova Partners Secures €1.2 Billion to Propel Life Sciences Investment and Innovation March 5, 2025
Sofinnova Partners Raises €1.2 Billion to Transform Life Sciences and Healthcare Investments March 5, 2025
Sofinnova Partners Secures €1.2 Billion to Propel Healthcare Innovations in Challenging Investment Landscape March 4, 2025
